New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 12, 2026

Back to the front page

From X

@StableBread

Fajasy on X

Fuel Tech $FTEK, the power plant pollution-control company, trades closer to its book value than to my updated sum-of-the-parts (SOTP). At $1.35/share, $FTEK trades 13.4% above its $1.19/share book value, and the market values the operating business at $14.3M ($42.1M market cap less $27.8M of cash and investments), ~0.5x TTM sales. Updating my August SOTP for the lower cash balance gives $1.65-2.10/share, 22-56% above today’s price, still with nothing for the data center pipeline or DGI (its technology for dissolving oxygen into water).
@valuedontlie

Colin King on X

Some initial $KBR RemainCo thoughts: Investors thought they were getting a ~20% margin business in STS which turns out to be 10% after corp costs + normalized JV earnings... some of this was expected, but looks like a bigger reset From that lower base, it's expected to grow 10% annually with 12%+ margins and minimal capex which is great No formal 2027 guidance but implying $425M EBITDA and $3.5B revenue (12% margin)... biggest no-no for spin-offs are mismanaging year 1 expectations from carve-out to standalone financials Capital allocation was sort of glossed over... dividend is gone, no commitment on buybacks, haven't done M&A at STS in 5+ years... They'll still pursue megaprojects (obv can't guide to these tho) so maybe some capital allocation goes there? 85% FCF conversion (from net income) is pretty low for an asset-light business too... sounds like this is a working capital intensive business model Hmm...
@aleabitoreddit

Serenity on X

So there's the positive fundamental long term outlook that I've interpreted. On the other hand, there's near term headwinds that I highlighted above, which markets are pricing in. Negatives I saw near term were $MSFT Vineland pushing back into Q2 2027, which delays revenue recognition. Alongside 2026/2027 capex hikes + downward revision of next quarter revenue. We've seen markets punish near term execution delays with $AAOI recently too. For long term, I don't see this earnings as negative, given 100% prepayments, compute prices going up, new contracts and their subsidiaries growing.

Investor Letters

All letters

Peloton: Beyond The Bike

Peloton’s connected-fitness subscribers fell 9% year over year to 2.475 million, with another high-single-digit holiday decline forecast as…

PTON $2.6B
TSOH Investment Research 3 clicks

DoorDash’s FBA Moment

DoorDash’s $17 billion Instacart deal targets DashMart warehouse scale, where 99%+ order accuracy and faster delivery address the limits of…

DASH $78BKR $41B
MBI Deep Dives 3 clicks
SRTA · long

Strata Critical Medical INC

Strata Critical Medical, SRTA, supplies organ-transport products tied to U.S. transplant growth.

SRTA $537M
Value Investors Club 3 clicks

On’s Premium Playbook

On Holdings targets premium growth through 2029, using LightSpray soccer cleats and higher pricing, with ASPs rising from $145 to $170…

ONON $12B
TSOH Investment Research 5 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 84 of 286

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

375 firms

Sectors

Ordered by how often our editor reaches for them.